Why no casopitant-only arm?
- PMID: 21178684
- DOI: 10.1097/ALN.0b013e318201668d
Why no casopitant-only arm?
Comment on
-
Phase II study to evaluate the safety and efficacy of the oral neurokinin-1 receptor antagonist casopitant (GW679769) administered with ondansetron for the prevention of postoperative and postdischarge nausea and vomiting in high-risk patients.Anesthesiology. 2010 Jul;113(1):74-82. doi: 10.1097/ALN.0b013e3181d7b13a. Anesthesiology. 2010. PMID: 20526194 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources